The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Schnyder corneal dystrophy (SCD) is an autosomal dominant disorder in humans characterized by abnormal accumulation of cholesterol in the cornea. SCD-associated mutations have been identified in the gene encoding UBIAD1, a prenyltransferase that synthesizes vitamin K2. Here, we show that sterols stimulate binding of UBIAD1 to the cholesterol biosynthetic enzyme HMG CoA reductase, which is subject to sterol-accelerated, endoplasmic reticulum (ER)-associated degradation augmented by the nonsterol isoprenoid geranylgeraniol through an unknown mechanism. Geranylgeraniol inhibits binding of UBIAD1 to reductase, allowing its degradation and promoting transport of UBIAD1 from the ER to the Golgi. CRISPR-CAS9-mediated knockout of UBIAD1 relieves the geranylgeraniol requirement for reductase degradation. SCD-associated mutations in UBIAD1 block its displacement from reductase in the presence of geranylgeraniol, thereby preventing degradation of reductase. The current results identify UBIAD1 as the elusive target of geranylgeraniol in reductase degradation, the inhibition of which may contribute to accumulation of cholesterol in SCD.

Original languageEnglish (US)
Article numbere05560
JournaleLife
Volume2015
Issue number4
DOIs
StatePublished - Mar 5 2015

Fingerprint

Dimethylallyltranstransferase
Hydroxymethylglutaryl CoA Reductases
Oxidoreductases
Degradation
Cholesterol
Sterols
Clustered Regularly Interspaced Short Palindromic Repeats
Endoplasmic Reticulum-Associated Degradation
Vitamin K 2
Mutation
Gene encoding
Terpenes
Endoplasmic Reticulum
Cornea
geranylgeraniol
Corneal Dystrophy, Crystalline, of Schnyder
Enzymes
Genes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)
  • Neuroscience(all)

Cite this

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase. / Schumacher, Marc M.; Elsabrouty, Rania; Seemann, Joachim; Jo, Youngah; DeBose-Boyd, Russell A.

In: eLife, Vol. 2015, No. 4, e05560, 05.03.2015.

Research output: Contribution to journalArticle

@article{05af7d7b030a40a9a0bc817a624a382c,
title = "The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase",
abstract = "Schnyder corneal dystrophy (SCD) is an autosomal dominant disorder in humans characterized by abnormal accumulation of cholesterol in the cornea. SCD-associated mutations have been identified in the gene encoding UBIAD1, a prenyltransferase that synthesizes vitamin K2. Here, we show that sterols stimulate binding of UBIAD1 to the cholesterol biosynthetic enzyme HMG CoA reductase, which is subject to sterol-accelerated, endoplasmic reticulum (ER)-associated degradation augmented by the nonsterol isoprenoid geranylgeraniol through an unknown mechanism. Geranylgeraniol inhibits binding of UBIAD1 to reductase, allowing its degradation and promoting transport of UBIAD1 from the ER to the Golgi. CRISPR-CAS9-mediated knockout of UBIAD1 relieves the geranylgeraniol requirement for reductase degradation. SCD-associated mutations in UBIAD1 block its displacement from reductase in the presence of geranylgeraniol, thereby preventing degradation of reductase. The current results identify UBIAD1 as the elusive target of geranylgeraniol in reductase degradation, the inhibition of which may contribute to accumulation of cholesterol in SCD.",
author = "Schumacher, {Marc M.} and Rania Elsabrouty and Joachim Seemann and Youngah Jo and DeBose-Boyd, {Russell A.}",
year = "2015",
month = "3",
day = "5",
doi = "10.7554/eLife.05560",
language = "English (US)",
volume = "2015",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",
number = "4",

}

TY - JOUR

T1 - The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase

AU - Schumacher, Marc M.

AU - Elsabrouty, Rania

AU - Seemann, Joachim

AU - Jo, Youngah

AU - DeBose-Boyd, Russell A.

PY - 2015/3/5

Y1 - 2015/3/5

N2 - Schnyder corneal dystrophy (SCD) is an autosomal dominant disorder in humans characterized by abnormal accumulation of cholesterol in the cornea. SCD-associated mutations have been identified in the gene encoding UBIAD1, a prenyltransferase that synthesizes vitamin K2. Here, we show that sterols stimulate binding of UBIAD1 to the cholesterol biosynthetic enzyme HMG CoA reductase, which is subject to sterol-accelerated, endoplasmic reticulum (ER)-associated degradation augmented by the nonsterol isoprenoid geranylgeraniol through an unknown mechanism. Geranylgeraniol inhibits binding of UBIAD1 to reductase, allowing its degradation and promoting transport of UBIAD1 from the ER to the Golgi. CRISPR-CAS9-mediated knockout of UBIAD1 relieves the geranylgeraniol requirement for reductase degradation. SCD-associated mutations in UBIAD1 block its displacement from reductase in the presence of geranylgeraniol, thereby preventing degradation of reductase. The current results identify UBIAD1 as the elusive target of geranylgeraniol in reductase degradation, the inhibition of which may contribute to accumulation of cholesterol in SCD.

AB - Schnyder corneal dystrophy (SCD) is an autosomal dominant disorder in humans characterized by abnormal accumulation of cholesterol in the cornea. SCD-associated mutations have been identified in the gene encoding UBIAD1, a prenyltransferase that synthesizes vitamin K2. Here, we show that sterols stimulate binding of UBIAD1 to the cholesterol biosynthetic enzyme HMG CoA reductase, which is subject to sterol-accelerated, endoplasmic reticulum (ER)-associated degradation augmented by the nonsterol isoprenoid geranylgeraniol through an unknown mechanism. Geranylgeraniol inhibits binding of UBIAD1 to reductase, allowing its degradation and promoting transport of UBIAD1 from the ER to the Golgi. CRISPR-CAS9-mediated knockout of UBIAD1 relieves the geranylgeraniol requirement for reductase degradation. SCD-associated mutations in UBIAD1 block its displacement from reductase in the presence of geranylgeraniol, thereby preventing degradation of reductase. The current results identify UBIAD1 as the elusive target of geranylgeraniol in reductase degradation, the inhibition of which may contribute to accumulation of cholesterol in SCD.

UR - http://www.scopus.com/inward/record.url?scp=84924303569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924303569&partnerID=8YFLogxK

U2 - 10.7554/eLife.05560

DO - 10.7554/eLife.05560

M3 - Article

C2 - 25742604

AN - SCOPUS:84924303569

VL - 2015

JO - eLife

JF - eLife

SN - 2050-084X

IS - 4

M1 - e05560

ER -